
Kim DH, Ko YG, Ahn CM, Shin DH, Kim JS, Kim BK, et al. Endovascular Therapy Outcomes and Intravascular Ultrasound Findings in Thromboangiitis Obliterans (Buerger's Disease).

Kawarada O, Kume T, Ayabe S, Nakaya T, Nakai M, Nishimura K, et al. Management of Buerger's Disease in Endovascular Era. Ghoneim BM, Karmota AG, Abuhadema AM, Shaker AA, Abdelmawla HM, Nasser MM, et al.
TAO DEFINITION HOW TO
How to Treat a Patient with Thromboangiitis Obliterans: A Systematic Review. 26 (3):387-95.įazeli B, Dadgar Moghadam M, Niroumand S. Clinical outcome after extended endovascular recanalization in Buerger's disease in 20 consecutive cases.

Graziani L, Morelli L, Parini F, Franceschini L, Spano P, Calza S, et al. A point scoring system for the clinical diagnosis of Buerger's disease. Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study. Kulkarni S, Kulkarni G, Shyam AK, Kulkarni M, Kulkarni R, Kulkarni V. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. 2022 Accessed: July 22, 2022.Ībyshov NS, Zakirdzhaev EA, Aliev ZM. Clinical characteristics of Buerger's disease in Iran. Salimi J, Tavakkoli H, Salimzadeh A, Ghadimi H, Habibi G, Masoumi AA. Thromboangiitis obliterans in the 21st century-a new face of disease. Buerger's disease: thromboangiitis obliterans 100 years after the initial description. Thrombo-angiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Ueber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangran des Fusses.
